ArticleGlobal health action2025
Trends in sales of sugar-sweetened beverages and associated type 2 diabetes burden in nine African countries: an ecological time-series analysis.
Article in Global health action, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Factors Influencing Water and Sweet Beverage Purchasing Decisions and Behaviours Among Low-Income Households in Four Peri-Urban Communities in Accra: An Exploratory Study.International journal of environmental research and public health · 2026Article
- Trends in sugar-sweetened beverage prices, sales, and elasticities: policy evidence from WHO regions, 2010-2024.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSugar-sweetened beverages (SSBs) are recognized contributors to the global rise in non-communicable diseases. While the link between SSB intake and adverse health outcomes is well established, long-term data from African countries are limited.
objectiveTo assess trends in SSB sales and their associations with type 2 diabetes (T2D) burden across nine African countries from 2010 to 2024.
methodsWe conducted an ecological time-series analysis using national-level data from Cameroon, Côte d'Ivoire, Ethiopia, Ghana, Kenya, Morocco, Nigeria, South Africa, and Uganda. Annual changes in per capita and total SSB sales, national T2D prevalence, and the number of adults with T2D were analyzed. Country-specific multivariate Vector Autoregressive (MVAR) models estimated associations between SSB sales and T2D outcomes.
resultsSSB sales rose across all countries, with the sharpest per capita increases in Cameroon (+173.8%), Nigeria (+119.1%), and Côte d'Ivoire (+88.5%). T2D trends varied: Ethiopia, Morocco, and South Africa showed rising prevalence and case numbers, while Ghana and Nigeria showed declines. Per capita SSB sales were significantly associated with adult T2D burden in Ghana (β = 0.41,
conclusionsRising SSB sales may be contributing to the T2D burden in African countries. This calls for context-specific regulatory measures, such as fiscal taxes and front-of-pack labels.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.